Literature DB >> 26755329

Physiological ranges of matrix rigidity modulate primary mouse hepatocyte function in part through hepatocyte nuclear factor 4 alpha.

Seema S Desai1, Jason C Tung1,2, Vivian X Zhou1, James P Grenert3,4, Yann Malato1, Milad Rezvani5, Regina Español-Suñer5, Holger Willenbring1,4,5, Valerie M Weaver1,2, Tammy T Chang1,4.   

Abstract

UNLABELLED: Matrix rigidity has important effects on cell behavior and is increased during liver fibrosis; however, its effect on primary hepatocyte function is unknown. We hypothesized that increased matrix rigidity in fibrotic livers would activate mechanotransduction in hepatocytes and lead to inhibition of liver-specific functions. To determine the physiologically relevant ranges of matrix stiffness at the cellular level, we performed detailed atomic force microscopy analysis across liver lobules from normal and fibrotic livers. We determined that normal liver matrix stiffness was around 150 Pa and increased to 1-6 kPa in areas near fibrillar collagen deposition in fibrotic livers. In vitro culture of primary hepatocytes on collagen matrix of tunable rigidity demonstrated that fibrotic levels of matrix stiffness had profound effects on cytoskeletal tension and significantly inhibited hepatocyte-specific functions. Normal liver stiffness maintained functional gene regulation by hepatocyte nuclear factor 4 alpha (HNF4α), whereas fibrotic matrix stiffness inhibited the HNF4α transcriptional network. Fibrotic levels of matrix stiffness activated mechanotransduction in primary hepatocytes through focal adhesion kinase. In addition, blockade of the Rho/Rho-associated protein kinase pathway rescued HNF4α expression from hepatocytes cultured on stiff matrix.
CONCLUSION: Fibrotic levels of matrix stiffness significantly inhibit hepatocyte-specific functions in part by inhibiting the HNF4α transcriptional network mediated through the Rho/Rho-associated protein kinase pathway. Increased appreciation of the role of matrix rigidity in modulating hepatocyte function will advance our understanding of the mechanisms of hepatocyte dysfunction in liver cirrhosis and spur development of novel treatments for chronic liver disease. (Hepatology 2016;64:261-275).
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26755329      PMCID: PMC5224931          DOI: 10.1002/hep.28450

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  50 in total

1.  Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis.

Authors:  Yong Zhou; Xiangwei Huang; Louise Hecker; Deepali Kurundkar; Ashish Kurundkar; Hui Liu; Tong-Huan Jin; Leena Desai; Karen Bernard; Victor J Thannickal
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 2.  From mechanical force to RhoA activation.

Authors:  Elizabeth C Lessey; Christophe Guilluy; Keith Burridge
Journal:  Biochemistry       Date:  2012-09-10       Impact factor: 3.162

3.  The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism.

Authors:  M Stoffel; S A Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  The microenvironment in hepatocyte regeneration and function in rats with advanced cirrhosis.

Authors:  Liping Liu; Govardhana Rao Yannam; Taichiro Nishikawa; Toshiyuki Yamamoto; Hesham Basma; Ryotaro Ito; Masaki Nagaya; Joyeeta Dutta-Moscato; Donna B Stolz; Fenghai Duan; Klaus H Kaestner; Yoram Vodovotz; Alejandro Soto-Gutierrez; Ira J Fox
Journal:  Hepatology       Date:  2012-04-04       Impact factor: 17.425

5.  A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats.

Authors:  S Tada; H Iwamoto; M Nakamuta; R Sugimoto; M Enjoji; Y Nakashima; H Nawata
Journal:  J Hepatol       Date:  2001-04       Impact factor: 25.083

6.  Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor beta-induced apoptosis.

Authors:  Patricio Godoy; Jan G Hengstler; Iryna Ilkavets; Christoph Meyer; Anastasia Bachmann; Alexandra Müller; Gregor Tuschl; Stefan O Mueller; Steven Dooley
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

7.  Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.

Authors:  H-Y Yue; C Yin; J-L Hou; X Zeng; Y-X Chen; W Zhong; P-F Hu; X Deng; Y-X Tan; J-P Zhang; B-F Ning; J Shi; X Zhang; H-Y Wang; Y Lin; W-F Xie
Journal:  Gut       Date:  2009-08-10       Impact factor: 23.059

8.  In vivo toxicity, metabolism and pharmacokinetic properties of FAK inhibitor 14 or Y15 (1, 2, 4, 5-benzenetetramine tetrahydrochloride).

Authors:  Vita Golubovskaya; Leslie Curtin; Adrienne Groman; Sandra Sexton; William G Cance
Journal:  Arch Toxicol       Date:  2014-06-12       Impact factor: 5.153

9.  Hepatocyte nuclear factor 4alpha controls the development of a hepatic epithelium and liver morphogenesis.

Authors:  Fereshteh Parviz; Christine Matullo; Wendy D Garrison; Laura Savatski; John W Adamson; Gang Ning; Klaus H Kaestner; Jennifer M Rossi; Kenneth S Zaret; Stephen A Duncan
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

10.  Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage.

Authors:  P P Provenzano; D R Inman; K W Eliceiri; P J Keely
Journal:  Oncogene       Date:  2009-12-10       Impact factor: 9.867

View more
  40 in total

1.  Transient Support from Fibroblasts is Sufficient to Drive Functional Vascularization in Engineered Tissues.

Authors:  H-H Greco Song; Alex Lammers; Subramanian Sundaram; Logan Rubio; Amanda X Chen; Linqing Li; Jeroen Eyckmans; Sangeeta N Bhatia; Christopher S Chen
Journal:  Adv Funct Mater       Date:  2020-06-25       Impact factor: 18.808

2.  Long-Term Engineered Cultures of Primary Mouse Hepatocytes for Strain and Species Comparison Studies During Drug Development.

Authors:  Brenton R Ware; Grace E Brown; Valerie Y Soldatow; Edward L LeCluyse; Salman R Khetani
Journal:  Gene Expr       Date:  2019-07-24

3.  Using non-thermal irreversible electroporation to create an in vivo niche for exogenous cell engraftment.

Authors:  Tammy T Chang; Vivian X Zhou; Boris Rubinsky
Journal:  Biotechniques       Date:  2017-05-01       Impact factor: 1.993

4.  Mechanotransduction in Liver Diseases.

Authors:  Ningling Kang
Journal:  Semin Liver Dis       Date:  2019-11-04       Impact factor: 6.115

Review 5.  Force-dependent breaching of the basement membrane.

Authors:  Tammy T Chang; Dhruv Thakar; Valerie M Weaver
Journal:  Matrix Biol       Date:  2016-12-23       Impact factor: 11.583

6.  Reply.

Authors:  Tammy T Chang
Journal:  Hepatology       Date:  2017-03-30       Impact factor: 17.425

7.  Matrix stiffness and shear stresses modulate hepatocyte functions in a fibrotic liver sinusoidal model.

Authors:  Wang Li; Peiwen Li; Ning Li; Yu Du; Shouqin Lü; David Elad; Mian Long
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-12-09       Impact factor: 4.052

8.  Lipid droplets disrupt mechanosensing in human hepatocytes.

Authors:  LiKang Chin; Neil D Theise; Abigail E Loneker; Paul A Janmey; Rebecca G Wells
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-05-28       Impact factor: 4.052

Review 9.  Engineered Biomaterial Platforms to Study Fibrosis.

Authors:  Matthew D Davidson; Jason A Burdick; Rebecca G Wells
Journal:  Adv Healthc Mater       Date:  2020-03-17       Impact factor: 9.933

10.  Matrix Softness-Mediated 3D Zebrafish Hepatocyte Modulates Response to Endocrine Disrupting Chemicals.

Authors:  Kathryn M Sullivan; Chang Gyun Park; John D Ito; Mikhail Kandel; Gabriel Popescu; Young Jun Kim; Hyunjoon Kong
Journal:  Environ Sci Technol       Date:  2020-10-19       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.